Viela Bio, Inc.
Overview
Viela Bio, Inc. is a biotechnology company focused on developing treatments for severe inflammation and autoimmune diseases. It was acquired by Horizon Therapeutics in 2021 and now operates as a subsidiary.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Viela Bio, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Verified Supplier Partner
Is this Viela Bio, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.